Abnormal fucosylation of CD276 has been reported in triple negative breast cancer (TNBC) and oral squamous cell carcinoma, and can inhibit the immune response in TNBC [39, 40]. The gene discussed is CD276; the disease is oral cavity squamous cell carcinoma.